Video Experimental Relacionado
Updated: Sep 9, 2025
13:08
Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
Published on: September 9, 2012
19.1K
Trombosis en hermanos con deficiencia de proteína S: serie de casos
Abate Bane Shewaye1,2, Seifu Kebede1, Amsalework Daniel1
1Department of Internal Medicine Adera Medical and Surgical Center Addis Ababa Ethiopia.
Clinical case reports
|September 4, 2025
Resumen
La deficiencia hereditaria de proteína S, una causa rara de coágulos sanguíneos, aumenta el riesgo de tromboembolismo venoso. El diagnóstico temprano y la anticoagulación son la clave para prevenir complicaciones graves.
Área de la Ciencia:
- Hematología
- La genética
- Medicina vascular
Sus antecedentes:
- La deficiencia hereditaria de proteína S es un trastorno genético raro.
- Es un factor de riesgo significativo para el tromboembolismo venoso (TEV).
- La TEV puede manifestarse en lugares inusuales, lo que plantea desafíos de diagnóstico.
Objetivo del estudio:
- Para resaltar la importancia clínica de la deficiencia hereditaria de proteína S.
- Hacer hincapié en la importancia del diagnóstico precoz y las estrategias de gestión.
- Discutir el papel del cribado familiar en las poblaciones en riesgo.
Principales métodos:
- Revisión de los casos clínicos y de los datos genéticos.
- Análisis de eventos trombóticos en pacientes con deficiencia de proteína S.
- Evaluación de la eficacia y seguridad de la anticoagulación.
Principales resultados:
- Se ha confirmado la asociación entre la deficiencia hereditaria de proteína S y el aumento del riesgo de TEV.
- Se ha demostrado la aparición de trombosis en sitios atípicos.
- Destacó la eficacia de la anticoagulación a largo plazo en la prevención de eventos recurrentes.
Conclusiones:
- La deficiencia hereditaria de proteína S requiere una rápida identificación y tratamiento.
- El cribado familiar es crucial para identificar a los familiares en riesgo.
- La anticoagulación a largo plazo es vital para mitigar las complicaciones de TEV y mejorar el pronóstico del paciente.
Videos de Conceptos Relacionados
01:20Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
33
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
33
01:30Venous Thrombosis I: Introduction
40
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
40
01:24Disorders of Hemostasis
1.2K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.2K
01:29Venous Thrombosis III: Interprofessional Care
22
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
22
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
888
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
888
01:24Nephrotic Syndrome I : Introduction
25
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
25